Subscribe: Market Wire - Medical and Healthcare: Medical Devices
http://img.marketwire.com/rss/mwMHMD.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  company  development  health  jan  january  marketwired jan  marketwired january  marketwired  medical  new  otc pink 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices



Marketwired - Medical Devices



Last Build Date: Fri, 20 Jan 2017 16:42:36 EST

Copyright: Copyright: (C) Marketwired
 



MedX Health Corp. Announces Amendments to $500,000 Term Loan

Fri, 20 Jan 2017 15:40:18 EST

MISSISSAUGA, ON--(Marketwired - January 20, 2017) - MedX Health Corp. ("MedX") (TSX VENTURE: MDX) announced that it has agreed with a lender to amend the terms of an original $500,000 Term Loan. Under the New Terms, the Lender has the right to convert the Principal of the Loan, in whole or part, at any time into common shares of MedX at $0.20 per share. In addition, the due date of the New Loan has been extended from June 26, 2018 to December 31, 2019, with no principal payments until maturity. "This change will improve the Company's cash flow management and thereby our ability to grow the business," noted Rob von der Porten, CEO. "We appreciate the confidence our lender has shown in MedX."




Navy Vet Celebrates 100th Birthday by Finishing Cancer Treatments

Fri, 20 Jan 2017 11:00:00 EST

Scripps proton therapy allows Carlsbad man to maintain active lifestyle




Servier Appoints MaSTherCell for the Development of its CAR-T Cell Therapy Manufacturing Platform

Fri, 20 Jan 2017 09:00:00 EST

GERMANTOWN, MD--(Marketwired - Jan 20, 2017) -   Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that its wholly-owned subsidiary, MaSTherCell S.A., specializing in the delivery of optimized process industrialization capacities to cell therapy organizations, has signed a master service agreement with Servier for the development of a manufacturing platform for allogeneic cell therapies. Under the master service agreement, MaSTherCell is developing a CAR-T cell therapy manufacturing platform, which will enable industrial and commercial manufacturing of Servier's cell therapy products. This is a critical step in the development of these products for later stage clinical trials.




Progressive Care Beats Expectations with over $18 Million in 2016 Revenues

Fri, 20 Jan 2017 08:30:00 EST

MIAMI, FL--(Marketwired - January 20, 2017) - Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces record breaking 2016.




Rennova Health's Pharmacogenomics Subsidiary Granted Patent

Fri, 20 Jan 2017 08:30:00 EST

WEST PALM BEACH, FL--(Marketwired - January 20, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that its Genomas, Inc. pharmacogenomics subsidiary has been granted a Patent by the US Patent and Trademark Office.




New Xtalks Webinar on Clinical Evaluation Reports (CERs): Global Benefits and The Impact of MEDDEV Updates to Manufacturers

Fri, 20 Jan 2017 07:30:00 EST

During a live broadcast, the speaker will examine the requirements listed in MEDDEV 2.7/1 revision. 4, discuss notable changes from MEDDEV 2.7/1 revision 3, while focusing on the global benefits of the Clinical Evaluation Report for your product's path to market.




Newly Created Standards Coordinating Body Seeks to Advance Development and Establishment of Regenerative Medicine Standards

Thu, 19 Jan 2017 15:23:19 EST

Builds upon call for standards development in 21st Century Cures Act




TEC Edmonton announces the opening of TEC Innovation District

Thu, 19 Jan 2017 13:30:00 EST

Edmonton's newest mentorship and co-working space for technology entrepreneurs




The Alliance for Regenerative Medicine Launches Standards Coordinating Body to Advance Development and Establishment of Industry-Wide Standards

Thu, 19 Jan 2017 12:22:41 EST

Builds upon call for standards development in 21st Century Cures Act




Somnia Anesthesia Hosts Its CRNA of the Year Contest During CRNA Week

Thu, 19 Jan 2017 10:00:00 EST

Nominations for Somnia's Sixth Annual CRNA of the Year Award Now Open




Amedica Announces Pricing of Public Offering to Raise $4.5 Million

Thu, 19 Jan 2017 09:46:33 EST

SALT LAKE CITY, UT--(Marketwired - Jan 19, 2017) -  Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced the pricing of an underwritten public offering of common stock and warrants with a public offering price of $0.51 for one share of common stock and 0.45 warrants. Each whole warrant is exercisable for one share of common stock. The Company expects to receive gross proceeds of approximately $4.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses. The Company has also granted a 45-day option to the underwriters to purchase up to an additional 15% of the shares of common stock plus up to 15% of the warrants; provided that in no event may the aggregate market value of securities sold in the offering, including from the over-allotment option, exceed the limitations set forth in Rule I.B.6 of Form S-3 solely to cover over-allotments, if any.




AssistRx Acquires Caret(TM), Providing Users with Cutting Edge Technology to Boost Patient Care Management, Adherence, and Compliance

Thu, 19 Jan 2017 09:01:00 EST

ORLANDO, FL--(Marketwired - Jan 19, 2017) -  AssistRx (ARx), the leading enterprise technology platform focused on simplifying the patient journey for specialty and highly-managed medications, today announces its acquisition of Caret, and Caret's Care Management Platform. Caret provides healthcare providers, specialty pharmacies, patients, and payers a best-in-class communication platform powered by actionable data such as point-of-service decision making, care management programs and near real-time updates on patients. ARx plans to integrate these features into the AssistRx Platform, to enhance the patient journey, drive quality-based healthcare, and improve outcomes.




70% of Global Drug Safety Teams Outsource Case Management Activities

Thu, 19 Jan 2017 07:44:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - January 19, 2017) - Data published by pharmaceutical competitive intelligence firm Cutting Edge Information found that literature services are the most commonly outsourced item among 70% of surveyed pharmacovigilance teams.




Vertical Integration of CRISPR/Cas9 Genome Engineering in Drug Discovery, New Webinar Hosted by Xtalks

Thu, 19 Jan 2017 07:30:00 EST

TORONTO, ON--(Marketwired - January 19, 2017) - Industry expert Dr. Anne-Marie Zuurmond, Associate Director of Genome Engineering, Discovery, Charles River Laboratories will discuss several CRISPR/Cas9 case studies during this webinar covering different aspects of the drug discovery process with an emphasis on the generation of in vitro models for high-throughput screening and the creation of new mouse models of disease.




Proto Script Pharmaceutical Corp. Building New Partnerships with Independent Practice Associations (IPA)

Thu, 19 Jan 2017 06:00:00 EST

RANCHO CUCAMONGA, CA--(Marketwired - Jan 19, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, today provided this update regarding its current business and future expansion plans with Independent Practice Associations.




Bio-Rad to Report Fourth-Quarter and Full-Year 2016 Financial Results Thursday, February 23, 2017

Wed, 18 Jan 2017 16:05:00 EST

HERCULES, CA--(Marketwired - Jan 18, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2016 on Thursday, February 23, 2017, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.




Esterline Invitation to 1st Quarter 2017 Earnings Conference Call

Wed, 18 Jan 2017 16:05:00 EST

BELLEVUE, WA--(Marketwired - Jan 18, 2017) - Esterline Technologies (NYSE: ESL)




Amedica Announces Proposed Public Offering of Common Stock and Warrants

Wed, 18 Jan 2017 16:01:00 EST

SALT LAKE CITY, UT--(Marketwired - Jan 18, 2017) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics, today announced that it intends to offer and sell common stock and warrants, subject to market and other conditions, in an underwritten public offering. The common stock and warrants are being offered under the Company's effective shelf registration statement previously filed with the Securities and Exchange Commission (SEC). Net proceeds from the offering will be used by Amedica to (1) remain in compliance with the financial covenants in its outstanding Loan and Security Agreement; (2) support working capital needs and other general corporate purposes; (3) fund research and development and commercialization activities of Amedica's product candidates, including the funding of clinical trials Amedica plans to conduct for its product candidates; and (4) continue to build sales, marketing and distribution capabilities for Amedica's silicon nitride technology platform and other products, including the costs of inventory and instruments.




PHZIO Telehealth Webinar Link

Wed, 18 Jan 2017 13:30:36 EST

CULVER CITY, CA--(Marketwired - Jan 18, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company successfully held its initial webinar this morning. Please see the following link to view this webinar: https://wnarchives.s3.amazonaws.com/45426582/62c11c14-baa2-4ad7-b8cd-521b38fd3542/archive.mp4. More information about our telehealth solution is available at our PHZIO.COM website: https://www.phzio.com




Megadyne Medical Named Utah's Most Innovative PR & Marketing Team 2016

Wed, 18 Jan 2017 13:00:00 EST

DRAPER, UT--(Marketwired - January 18, 2017) - Megadyne Medical Products, The Electrosurgical Authority® and full-solution electrosurgical provider, was recently named Utah's Most Innovative PR & Marketing Team 2016 by Corporate America News magazine. According to the online publication based in New York City, this prestigious award was granted to the medical device company based on its impressive presence across media, as well as client recommendations and referrals from other agencies who have witnessed the impact of Megadyne through its various PR and marketing initiatives.







Konica Minolta Healthcare Americas Partners with 7Dimaging to Strengthen its Educational Offering

Wed, 18 Jan 2017 09:40:00 EST

WAYNE, NJ--(Marketwired - January 18, 2017) - Konica Minolta Healthcare Americas, Inc., a leading provider in musculoskeletal ultrasound (MSK), has partnered with 7Dimaging to strengthen its educational resources by offering the mskNAVT Education Tool.




Beazley adds life sciences underwriter in San Francisco

Wed, 18 Jan 2017 09:02:41 EST

SAN FRANCISCO, CA--(Marketwired - January 18, 2017) - Beazley, a leading provider of specialist miscellaneous medical insurance, has strengthened its miscellaneous medical underwriting team with the hire of life sciences underwriter Marc Amis in its San Francisco office. This is the latest addition to Beazley's growing team addressing the needs of organizations across the healthcare industry, with a focus on hard to place risks.




VPR Brands, LP will be Re-Launching the STINGER at the BIG Industry in Los Angeles California

Wed, 18 Jan 2017 08:30:00 EST

FORT LAUDERDALE, FL--(Marketwired - Jan 18, 2017) - VPR Brands, LP (OTC PINK: VPRB) is proud to announce its participation in the 2017 Big Industry Show in Los Angeles, California on January 19-20th where we will be showcasing our flagship product, the STINGER, part of our Honey Stick Brand.




MTBC in 2016 -- An Exciting Year in Review

Wed, 18 Jan 2017 08:30:00 EST

A recollection of important corporate highlights




Biomerica Announces Second Quarter Financial Results; Sales up Over 22% for the Quarter

Wed, 18 Jan 2017 08:19:00 EST

IRVINE, CA--(Marketwired - January 18, 2017) - Biomerica, Inc. (NASDAQ: BMRA) today reported net sales of $1,432,206 for the three months ended November 30, 2016, compared to $1,165,080 for the same period in the previous year, an increase of 22.9%. Net sales were $2,842,317 for the first six months of fiscal 2017 compared to $2,452,073 for the first six months in fiscal 2016, an increase of 15.9%.




Pharma Compliance Teams Approving Physician Compensation Cap Exceptions

Wed, 18 Jan 2017 08:17:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - January 18, 2017) - Although more pharmaceutical companies have instituted compensation limits as a response to scrutiny over their payments to physicians, there are still exceptions to those rules.




Vystar to Co-Present on Latex Medical Devices at India Rubber Expo

Wed, 18 Jan 2017 07:53:45 EST

ATLANTA, GA--(Marketwired - Jan 18, 2017) - Vystar Corp.'s (OTC PINK: VYST) CEO Mr. William Doyle and Member of the Board of Directors and Director of R&D Dr. Ranjit Matthan will join Mr. Sivanyana Moorthy Nadesan of Sibelco Malaysia Sdn Bhd to present "The Manufacture and Markets of Medical Elastomeric Devices-Prospects and Challenges" at the India Rubber Expo (IRE) in Chennai India on January 21, 14:00-18:00, Hall #2.




Upcoming Webinar on Development by Design: Hovione's Approach to Spray Drying Process Development

Wed, 18 Jan 2017 07:30:00 EST

TORONTO, ON--(Marketwired - January 18, 2017) - On Tuesday, January 31, 2017, Xtalks will host a complimentary webinar featuring Márcio Temtem, Associate Director of Particle Design and Formulation Development at Hovione and João Vicente, Team Leader of Particle Engineering and Solubility Enhancement at Hovione, as the keynote speakers.




MediXall Appoints Dr. Pedro A. Sanchez, D.O., to be its First Medical Director

Wed, 18 Jan 2017 07:30:00 EST

FT. LAUDERDALE, FL--(Marketwired - Jan 18, 2017) - MediXall Group, Inc. (OTCQB: MDXL) is pleased to announce the appointment of its first Medical Director, Dr. Pedro A. Sanchez, D.O. Dr. Sanchez is a graduate of Southeastern College of Osteopathic Medicine in Ft. Lauderdale, Florida, and served his residency at Wellington Regional Medical Center in Wellington, Florida. Dr. Sanchez is Board Certified by the American Osteopathic Board of Family Physicians, and has been a successful family practice physician for over 25 years.




Omni Health, Inc. names Andrey Soloviev as New CEO

Wed, 18 Jan 2017 07:25:04 EST

MIAMI, FL--(Marketwired - Jan 18, 2017) -  Omni Health, Inc., (OTC PINK: OMHE), a pharmaceutical company, announced today the Board of Directors has selected Andrey Soloviev as its new Chief Executive Officer. Mr. Soloviev will take over, effective immediately, for interim CEO, Michael Hawkins, who shall remain the company's interim CFO. 




EPIC the Dividend and Outside the Box Company Presents the TRANSFORMED EPIC

Wed, 18 Jan 2017 05:00:00 EST

AUSTIN, TX--(Marketwired - January 18, 2017) - EPIC Corporation (OTC PINK: EPOR) ("EPIC"), and Ronald S. Tucker announced "EPIC the Dividend and Outside the Box Company is now the TRANSFORMED EPIC."




Rand Capital to Present at NobleCon13

Tue, 17 Jan 2017 16:15:00 EST

BUFFALO, NY--(Marketwired - January 17, 2017) - Rand Capital Corporation (NASDAQ: RAND) ("Rand"), a venture capital company whose focus is to make investments in companies with emerging product, service or technology concepts, today announced that Allen ("Pete") F. Grum, President and Chief Executive Officer, and Daniel P. Penberthy, Executive Vice President and Chief Financial Officer, will be participating at the Noble Financial Capital Markets 13th Annual Investor Conference (NobleCon13) on Monday, January 30, 2017 in Boca Raton, Florida.




B. Braun Medical and Overlook Medical Center's Collaborative Peripheral IV Catheter Educational Outcomes Research Results Published in the Journal of the Society for Simulation in Healthcare

Tue, 17 Jan 2017 15:20:00 EST

BETHLEHEM, PA--(Marketwired - Jan 17, 2017) - B. Braun Medical Inc. collaborated with Overlook Medical Center, part of New Jersey-based Atlantic Health System, to conduct a randomized trial assessing the impact of B. Braun's proprietary blended, simulation-based educational intervention on staff nurses' peripheral intravenous catheter (PIVC) knowledge, confidence, and procedural skills. The study results showed significant improvements in these areas in a simulated environment.1 The research manuscript was published in the December issue of Simulation in Healthcare.




Greenhealth Exchange Sees Significant Growth in 2016

Tue, 17 Jan 2017 12:00:00 EST

Innovative green purchasing cooperative gains market traction, sets goals for 2017




Medifirst Solutions to Present Its Time Machine Laser in Morocco and Dubai

Tue, 17 Jan 2017 11:00:00 EST

FREEHOLD, NJ--(Marketwired - Jan 17, 2017) - MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst") would like to update shareholders regarding its previous announcement about international sales for its FDA cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.




CB Insights Reveals the AI 100 List At The Innovation Summit

Tue, 17 Jan 2017 11:00:00 EST

CloudMedx Inc Selected to the 2017 AI 100, Highlighting Advancements in Clinical AI Insights at All Points of Care




Solos Endoscopy, Inc. Retains Consulting Firm

Tue, 17 Jan 2017 10:44:09 EST

BOSTON, MA--(Marketwired - Jan 17, 2017) - Solos Endoscopy, Inc. (OTC PINK: SNDY) a provider of quality innovative medical devices to hospitals across the country, is pleased to announce that the company has engaged the consulting services of AMG Development LLC to assess the restructuring and outlining of a growth strategy for the company. In addition, AMG Development principal, Dom Gatto, will oversee executive management responsibilities for the company and guide the company during this pivotal time.




Tufts Clinical and Translational Science Institute and Baim Institute for Clinical Research Announce Partnership

Tue, 17 Jan 2017 10:10:00 EST

Students, Faculty, Researchers, and Patients to Benefit from New Collaboration




Advantis Corp. Boosts Bottom Line, Reduces Debt

Tue, 17 Jan 2017 09:26:00 EST

NEWPORT BEACH, CA--(Marketwired - Jan 17, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it has settled into its new commercial space to meet surging demand of Amstercan, rosin presses, and other products. The company has also announced that it has reduced debt by $250,000.




GeoVax to Collaborate with Georgia State University on Development of Therapeutic Hepatitis B Vaccine

Tue, 17 Jan 2017 09:00:00 EST

Targeting Chronic Hepatitis B Infections Affecting More Than 240 Million People Worldwide




PHZIO Telehealth Clinic Orientation and On-boarding

Tue, 17 Jan 2017 09:00:00 EST

CULVER CITY, CA--(Marketwired - Jan 17, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company is pleased to announce that it has begun clinic orientation and on-boarding of selected PT's at Motion PT Group and our other previously announced PT clinic licensees. More information about our telehealth solution is available at our PHZIO.COM website: https://www.phzio.com




Advanced Proteome Therapeutics Corporation Announces Issuance of U.S. Patent Covering Novel Molecules for the Treatment of Cancer

Tue, 17 Jan 2017 09:00:00 EST

VANCOUVER, BC--(Marketwired - January 17, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce issuance of APC's U.S. Patent Application 14/400,190 titled "Site-Specific Labeling and Targeted Delivery of Proteins for the Treatment of Cancer".




Progressive Care: PharmCo Opens Resource Center in Century Village

Tue, 17 Jan 2017 08:30:00 EST

MIAMI, FL--(Marketwired - January 17, 2017) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces a new Resource Center for the exclusive use for residents of Century Village of Pembroke Pines, FL.




Pharmaceutical Key Account Managers Favor Hospital System Accounts

Tue, 17 Jan 2017 08:17:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - January 17, 2017) - The majority of surveyed pharmaceutical key account manager (KAM) groups are most likely to support hospital system accounts (88%) and regional/local-level government payers (76%), according to recent data published by competitive intelligence provider Cutting Edge Information.




Glue Named Top 20 New York Ad Agency

Tue, 17 Jan 2017 08:00:00 EST

NEW YORK, NY--(Marketwired - Jan 17, 2017) - Glue Advertising was recently recognized as one of the top 20 advertising agencies in New York. Expertise.com ranked just under 2,000 agencies in the city on 25 variables, across 5 categories, and distinguished Glue for its quality of customer service.




Royal Solutions Group and Client Outlook enter a strategic partnership to resell eUnity

Tue, 17 Jan 2017 08:00:00 EST

WATERLOO, ON--(Marketwired - January 17, 2017) - Client Outlook, a leading provider of FDA Class II diagnostic and clinical image viewing solutions, announced today that Royal Solutions Group has selected eUnityT as its enterprise image viewing platform. Royal Solutions Group delivers best in class interoperable healthcare solutions, focusing on patient engagement with a patient portal and onsite kiosk, referral management with computerized order entry, as well as result and image delivery, and revenue cycle management, with an industry leading real-time eligibility, estimates and payments engine. Integrating eUnity as part of the Royal Solutions offering enhances the end-user experience by providing high quality images to both physicians and patients.




XOR-Labs adds experienced medical device executive Steven Plymale to Board of Directors

Tue, 17 Jan 2017 08:00:00 EST

TORONTO, ON--(Marketwired - January 17, 2017) - XOR-Labs Toronto Inc. (XOR), a spin-off from Toronto General Hospital at University Health Network the world's leading center for lung transplantation and a MaRS Innovation company, today announced the appointment of Steven Plymale as an Independent Director to its Board. Mr. Plymale is the President and COO of Profound Medical, (TSX VENTURE: PRN), an emerging medical device company that is commercializing a real time MR image guided thermal ultrasound ablation treatment for prostate disease. Mr. Plymale has a strong track record of building medical technologies from the critical early stages of product development through operational scale-up and clinical and regulatory pathway development. With this addition, XOR continues to add independent oversight, diversity, and expertise.




Ritter Pharmaceuticals Appoints William Merino, Ph.D., to its Board of Directors

Tue, 17 Jan 2017 08:00:00 EST

LOS ANGELES, CA--(Marketwired - Jan 17, 2017) - Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a developer of novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced it has appointed William Merino, Ph.D., to its Board of Directors. Dr. Merino will occupy a newly-created seat, advising on regulatory, clinical and related strategies.




Psoria-Shield, Inc. Signs Distribution Agreement with NewSurg

Tue, 17 Jan 2017 08:00:00 EST

HOFFMAN ESTATES, IL--(Marketwired - Jan 17, 2017) - Wellness Center USA, Inc. (OTCQB: WCUI), today announced that its wholly-owned subsidiary, Psoria-Shield, Inc. (PSI), has signed a non-exclusive distribution agreement with NewSurg to sell the Psoria-Light® (PL 1000) in the United States. NewSurg, located in Bucks County, PA, develops and distributes next generation medical lasers and equipment for cosmetic and medical practices.




Ventripoint Announces Filing of Application for Complete Heart Analysis System With Health Canada

Tue, 17 Jan 2017 07:40:35 EST

TORONTO, ONTARIO--(Marketwired - Jan. 17, 2017) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSX VENTURE:VPT) announces that it has filed an application with Health Canada for approval of the expansion of the VMST heart analysis product to include right atrium (RA), left atrium (LA) and left ventricle (LV) chambers of the heart. The VMS is already licensed in Canada for use for the right ventricle (RV). This expansion allows the determination of volume and function for all four chambers of the heart using conventional 2D ultrasound and reduces the need for costly and delayed MRI exams, which is the only other way to get accurate and reliable measurements.




Study Shows Improved Primary Adherence as high as 99% using InstyMeds Automated Direct-to-Patient Dispensers

Tue, 17 Jan 2017 07:00:00 EST

MINNEAPOLIS, MN--(Marketwired - Jan 17, 2017) - A 2017 study conducted at the University of Minnesota and published in the journal ClinicoEconomics and Outcomes Research found patients that have their medications dispensed at the point of care have much higher rates of adherence.




Proto Script Pharmaceutical Corp. discusses Opportunities in the Expanding US Power Wheelchair and Mobility Scooter Market

Tue, 17 Jan 2017 06:00:00 EST

RANCHO CUCAMONGA, CA--(Marketwired - Jan 17, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, is pleased to provide this discussion regarding opportunities in the expanding US power wheelchair and mobility scooter market.




Rennova Health Completes Asset Purchase Agreement of Scott County Community Hospital

Tue, 17 Jan 2017 06:00:00 EST

WEST PALM BEACH, FL--(Marketwired - January 17, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that it has closed the previously reported Asset Purchase Agreement to acquire certain assets related to Scott County Community Hospital, based in Oneida, Tennessee ("Scott County Hospital").




Phoseon Technology se lance sur le marché de la biologie

Tue, 17 Jan 2017 00:00:00 EST

Nouvel accent et nouvelles possibilités pour la technologie LED brevetée




Phoseon Technology steigt in den Life-Sciences-Markt ein

Tue, 17 Jan 2017 00:00:00 EST

Neuer Schwerpunkt und neue Möglichkeiten für patentierte LED-Technologie




Phoseon Technology Enters Life Sciences Market

Tue, 17 Jan 2017 00:00:00 EST

New focus and capabilities for patented LED Technology




Stephen Petranek in den Aufsichtsrat von NexOptic berufen

Mon, 16 Jan 2017 18:22:04 EST

VANCOUVER, KANADA --(Marketwired - 16. Januar 2017) - NexOptic Technology Corp. ("NexOptic") (OTCQB: NXOPF) (TSX VENTURE: NXO) (FRANKFURT: E301) (BERLIN: E301) und Spectrum Optix Inc. aus Calgary, Kanada ("Spectrum,") und gemeinsam mit NexOptic, im Folgenden "Unternehmen") freuen sich bekannt geben zu dürfen, dass Herr Stephen Petranek dem Aufsichtsrat der NexOptic Technology Corp beigetreten ist.




Helius Medical Technologies Announces Launch of Sixth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial

Mon, 16 Jan 2017 09:31:20 EST

NEWTOWN, PENNSYLVANIA--(Marketwired - Jan. 16, 2017) - Helius Medical Technologies, Inc. (TSX:HSM)(OTCQB:HSDT) ("Helius" or the "Company") is pleased to announce that MedStar National Rehabilitation Hospital in Washington D.C., has been launched as the sixth site to provide services supporting Helius' ongoing pivotal trial investigating PoNST Therapy for the treatment of subjects with balance disorder resulting from mild to moderate Traumatic Brain Injury (TBI). Clinical trial sites in the U.S. and Canada include Oregon Health and Science University in Portland OR, Montreal Neurofeedback Center in Montreal, QB, Orlando Regional Medical Center in Orlando, FL, HealthTech Connex Inc. in Surrey, BC and Virginia Commonwealth University in Richmond, VA.




Health Advance Inc. Announces the Closing of the Acquisition of Hantian Labs

Mon, 16 Jan 2017 09:00:00 EST

LAS VEGAS, NV--(Marketwired - Jan 16, 2017) - Health Advance Inc. (the "Company") (OTC PINK: HADV) is pleased to announce that the Company has closed the Share Exchange Agreement ("Agreement") to acquire Hantian Labs Limited, a private UK corporation (Hereinafter referred to as "Hantian"). As a result of the acquisition, Health Advance will also control 99% of JT Hantian LLC representing the revenue arm of Hantian. Pursuant to the Agreement, the Company has issued 18,000,000 common shares of the Company to the shareholders of Hantian Labs representing the purchase price of Hantian. Accordingly, the Company's issued and outstanding number of common shares increased from 26,520,000 shares to 44,520,000 shares. In addition, Company has waived Hantian's undertaking to raise a minimum financing of $250,000 for marketing of Hantian's product line prior to closing.




Bio-Rad to Acquire RainDance Technologies and Droplet Intellectual Property

Mon, 16 Jan 2017 08:30:00 EST

HERCULES, CA--(Marketwired - Jan 16, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, announced today that it has entered into a definitive agreement to purchase RainDance Technologies, Inc. The terms of the acquisition were not disclosed. Bio-Rad expects the transaction to close during the first quarter of 2017. The company will discuss the acquisition further during Bio-Rad's upcoming fourth-quarter and full-year 2016 financial results conference call. 




The Steadman Clinic, SPRI and Smith & Nephew Host Annual Vail Hip Symposium

Fri, 13 Jan 2017 18:25:39 EST

Three-day Event at Westin Riverfront Resort Highlights Latest Methods of Treating Hip Injuries and Rehabilitation